Healthcare DIVE November 23, 2022
Centene inked a deal to sell Magellan Specialty Health for more than $750 million to Evolent Health.
It’s the latest divestiture in Centene’s plan to sell non-core assets as part of a long-term strategy to improve the company’s profit margin.
“This transaction is another significant milestone in our ongoing portfolio review and value creation plan,” CEO Sarah London said in a statement.
In July, Centene announced plans to sell its international assets to a private hospital operator in France. Centene is underway on a review of every unit within the company to determine whether it should remain.
Magellan Specialty Health, also known as NIA, provides utilization management services. The unit was previously...